2 ASX shares to buy today with $10,000

This might be a rare chance to pick up premium stocks at a steep discount. The post 2 ASX shares to buy today with $10,000 ...

Here's Ord Minnett's updated view on Macquarie and CSL shares

Ord Minnett sees one as a buy and one to hold. The post Here's Ord Minnett's updated view on Macquarie and CSL shares ...
EurekAlert!

Periods may trigger pain for many who have sickle cell disease

Pain related to sickle cell disease (SCD) increases during menstruation, as do emergency department (ED) visits and hospitalizations, for many women and girls — according to a new, nationwide study ...
PharmExec

Eli Lilly Enters $100 Million Licensing Agreement with CSL Limited for Clazakizumab

Exclusive licensing grants Lilly development and commercialization rights for clazakizumab beyond ESKD-related cardiovascular prevention, while CSL retains the ESKD cardiovascular events indication.
Fierce Biotech

Lilly pays CSL $100M upfront for IL-6 antibody that flunked a phase 3 organ transplant study

Eli Lilly is paying $100 million upfront (PDF) for the right to develop CSL’s phase 3-stage IL-6 antibody that had previously been explored for organ transplant rejection.